Navigation Links
NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain
Date:10/28/2009

MAPLE GROVE, Minn., Oct. 28 /PRNewswire/ -- NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that the first procedure in Spain utilizing its cPAX Aneurysm Treatment System was performed in Madrid. cPAX received CE Mark earlier this year.

Dr. Alfredo Casasco, Interventional Neuroradiology, Department of Endovascular and Percutaneous Treatment, Clinica Nuestra Senora del Rosario, used 143cm of cPAX in combination with platinum coils to treat an unruptured aneurysm over 13mm in diameter.

"According to the AngioCalc aneurysm volume calculator, greater than 40% packing density was achieved with cPAX alone, which we see as a great result," said Kathryn Meintsma, Vice President of Marketing, NeuroVasx. "Studies have indicated that aneurysms packed greater than 24% have a lower incidence of recanalization."(1,2)

"We are very pleased with the outcome of the first procedure in Spain, which demonstrates the sophisticated filling capabilities of cPAX in large aneurysms," said Eric B. Timko, President and Chief Executive Officer, NeuroVasx. "cPAX was designed to simplify delivery, shorten procedure time and improve outcomes, and the product's polymer characteristics make it ideally suited to take on the shape of large aneurysms and attain maximized packing density. This case marks a significant milestone in our entry into the European market and we look forward to continuing to introduce cPAX throughout the EU."

The cPAX System is a minimally invasive device for the embolization of cerebral aneurysms, abnormal bulges or sacs in the wall of an artery in the brain. If ruptured, aneurysms can result in massive intracranial bleeding and often lead to death. cPAX is a polymer strand delivered through a microcatheter using the same delivery technique as the currently used platinum coil technology. cPAX was designed to achieve more complete filling of the aneurysm using fewer devices and provide the physician the ability to detach the device at any point versus the fixed detachment zone common to platinum coils. The polymeric material also allows for non-invasive CT and MRI scans free of metallic artifact for a more accurate patient follow-up assessment.

  1. Tamatani S, Ito Y, Abe H, et al: Evaluation of the stability of aneurysms after embolization using detachable coils: Correlation between stability of aneurysms and embolized volume of aneurysms. AJNR May 2002, 23:762-767.
  2. Sluzewski M, Willem JvR, Slob MJ, et al: Relation between aneurysm volume, packing, and compaction in 145 cerebral aneurysms treated with coils. Radiology 2004; 231:653-658.

About Cerebral Aneurysms

A cerebral aneurysm is an abnormal bulge or sac in the wall of an artery in the brain which can be caused by a number of factors including congenital defects, high blood pressure, atherosclerosis, cancer, drug use or head trauma. If a cerebral aneurysm ruptures, it can lead to a hemorrhagic stroke, or bleeding on the brain. According to National Institutes of Health, approximately 40% of these patients do not survive the first 24 hours. The worldwide incidence of cerebral aneurysms is estimated to be 320,000 annually, approximately 200,000 of which may be treatable with intracranial surgery or minimally invasive techniques.

About NeuroVasx, Inc.

NeuroVasx, Inc. (http://www.neurovasx.com/) is a privately held medical device company located in Maple Grove, MN. The company is dedicated to the development and commercialization of technologies for the minimally invasive treatment of hemorrhagic and ischemic stroke. The worldwide market potential for stroke treatment devices is estimated to be over $3 billion.

    Contact:                                    Media Contacts:
    Eric B. Timko                               Jennifer Saunders
    President and CEO                           The Ruth Group
    NeuroVasx                                   646-536-7011
    763-315-0013                                jsaunders@theruthgroup.com

SOURCE NeuroVasx, Inc.


'/>"/>
SOURCE NeuroVasx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
2. NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic Trainers’ ... during the summer of 2016. The program was made possible by a Pennsylvania ... Department of Health and Human Services Administration. The broadcast, Use Your Head: ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio ... the first national #QuackGivesBack campaign which supported local breast cancer organizations during National ... Quack Gives Back initiative, and we’re very pleased with the participation ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the ... advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, ... Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up with ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce ... service for Texas, they are expanding their presence in Dallas. One of the most ... will bring new jobs to the Dallas and Forth Worth market. STAT takes pride ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... 8, 2016 Global Interventional Radiology Market: ... global interventional radiology market analyzes the current and ... an elaborate executive summary, including a market snapshot ... sub-segments. The research is a combination of ... bulk of our research efforts along with information ...
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
Breaking Medicine Technology: